CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer
Authors 0
- Author list not loaded yet.
Cited by 3 stored of 96
3 results
3 results